Nitinotes Completes First Patient Treatment in Groundbreaking EASE™ Trial for Automated Suturing System Nitinotes Ltd. successfully treated the first patient in their EASE™ clinical trial for the EndoZip™ suturing system, aiming to advance obesity treatment.

Nitinotes Completes First Patient Treatment in Groundbreaking EASE™ Trial for Automated Suturing System #USA #New_York #EASE_Trial #EndoZip #Nitinotes

Nitinotes Enters New Frontier with EASE Clinical Trial and First Patient Treated Using EndoZip System Nitinotes Ltd. has announced the successful treatment of the first patient in its pivotal EASE Clinical Trial, showcasing the EndoZip automated suturing system for obesity treatment.

Nitinotes Enters New Frontier with EASE Clinical Trial and First Patient Treated Using EndoZip System #United_States #New_York #ESG #EndoZip #Nitinotes

Nitinotes Achieves CE Mark Approval for Revolutionary EndoZip Suturing System in Obesity Treatment Nitinotes Ltd. has secured CE Mark approval for the EndoZip™ System, transforming endoscopic sleeve gastroplasty procedures in Europe.

Nitinotes Achieves CE Mark Approval for Revolutionary EndoZip Suturing System in Obesity Treatment #Israel #Caesarea #Obesity_Treatment #EndoZip #Nitinotes

Nitinotes' EndoZip™ Receives CE Mark, Revolutionizing Obesity Treatment with Automated Suturing System Nitinotes Ltd. is set to transform obesity treatment with its newly CE Mark approved EndoZip™ system, enabling efficient outpatient endoscopic procedures.

Nitinotes' EndoZip™ Receives CE Mark, Revolutionizing Obesity Treatment with Automated Suturing System #Israel #Caesarea #ESG #EndoZip #Nitinotes

Nitinotes Secures FDA Approval for Pivotal Trial of EndoZip™ System for Obesity Treatment Nitinotes has gained FDA approval for initiating a crucial clinical trial of its EndoZip™ automated suturing system aimed at treating obesity. This trial is a significant step in advancing minimally invasive bariatric surgery.

Nitinotes Secures FDA Approval for Pivotal Trial of EndoZip™ System for Obesity Treatment #Israel #FDA_Approval #Caesarea #Nitinotes #EndoZip™

Nitinotes Receives FDA Approval for Pivotal Trial of EndoZip™ System in Obesity Treatment Nitinotes has received FDA approval to start a pivotal trial for the EndoZip™ System, a breakthrough in obesity treatment via endoscopic sleeve gastroplasty.

Nitinotes Receives FDA Approval for Pivotal Trial of EndoZip™ System in Obesity Treatment #USA #Caesarea #Obesity_Treatment #Nitinotes #EndoZip™

Promising Interim Clinical Results for EndoZip™ Unveiled at IFSO-EC 2025 Congress At the IFSO-EC 2025 Congress, innovative interim results for the EndoZip™ endoscopic suturing system show significant safety and weight loss benefits for patients with obesity and comorbidities.

Promising Interim Clinical Results for EndoZip™ Unveiled at IFSO-EC 2025 Congress #Israel #Caesarea #Obesity_Treatment #EndoZip #Nitinotes